Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Clinical protocol for phase I/II testing of tgAAV-CFTR

June 5, 1998

Zyrtec approved for use in children as young as two years

June 5, 1998

Neurokinin antagonists in the pipeline at Schering-Plough

June 4, 1998

Byk Gulden's new PDE IV inhibitors

June 4, 1998

AxyS files IND for dry powder inhalation formulation of APC-366

June 4, 1998

Nikken Chemicals presents new antiasthmatic agents

June 3, 1998

New lipoxygenase inhibitors for asthma and other inflammatory conditions

June 2, 1998

New tachykinin antagonists patented by Pfizer

May 29, 1998

Neurokinin antagonists for bronchoconstriction, neurogenic inflammation

May 29, 1998

Multiple-dose pharmacokinetics/pharmacodynamics reported for ABT-761

May 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...